Serum Levels of Interleukin-1β and Disease Progression in Multiple Myeloma Patients: A Case and Control Study.

Objective: Multiple myeloma  (MM) is known as an incurable heterogeneous plasma cell malignancy that presents with a variety of clinical manifestations. Inflammation plays an important role in this disease. Cytokines and Chemokines cause the progression of the disease.